Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185666 · ClinicalTrials.gov registry record · Phase 1
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
A Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00185666 is a Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers that has completed, run by Stanford University. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00185666, a Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.
Conditions Studied
Interventions
- PROCEDURE Stereotactic radiosurgery
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-05 |
| Est. Completion | 2006-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185666
The ClinicalTrials.gov registry entry for NCT00185666 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spinal Cord Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic radiosurgery is the first listed.
NCT00185666 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00185666 about?
NCT00185666 is a clinical study titled "Cyberknife Precision Radiation Delivery System for Tumors of the Spine". The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.
What is the current status of trial NCT00185666?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2002-05. Estimated completion is 2006-05.
What conditions does trial NCT00185666 study?
This clinical trial studies the following conditions: Spinal Cord Cancer, Brain (Nervous System) Cancers.
What interventions are being tested in trial NCT00185666?
The interventions under investigation include: Stereotactic radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00185666?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185666 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.